On 13 March, BioMérieux China signed a strategic cooperation agreement with Accunome Biotechnology Co., Ltd.

Yu Linwei, member of the Standing Committee of the District Party Committee and Vice Mayor of the District, delivered a speech on behalf of the People's Government of Xuhui District, expressing the hope that both parties would give full play to their brands, technologies and platform advantages in the field of biomedicine, and fully tap into domestic and international resources to help Xuhui's life and health industry grow and accelerate its development. Mr. Burleigh, Executive Vice President of Global Clinical Operations and Chief Operating Officer of BioMérieux, introduced the global head office of BioMérieux and congratulated BioMérieux on its 30th anniversary in China. Yang Xing, Founder and CEO of Accunome, expressed the importance of the strategic cooperation between the two companies. Chen Weiwei, Vice President of BioMérieux Greater China, introduced the current situation of BioMérieux China and the future development prospects in the region.

(Speech by Yu Linwei, Standing Committee Member of the District Committee and Deputy District Governor)

(BioMérieux's Executive Vice President of Global Clinical Operations and Chief Operating Officer, Burleigh, presents the Mérieux Global Head Office)

(Yang Xing, Founder and CEO of Accunome, introduces the importance of this strategic cooperation)

(Chen Weiwei, Vice President and General Manager of BioMérieux Greater China, presents the current situation and prospects of Mérieux in China)

At the meeting, Chen Weiwei and Yang Xing signed a strategic cooperation agreement on behalf of both units. Yu Linwei, Yu Wei, Deputy Director of the District Science and Technology Commission, Huang Libo, Chairman of Fenglin Group, Burleigh, Executive Vice President of Global Clinical Operations and Chief Operating Officer of BioMérieux, Ran Ruibo, Senior Vice President of Clinical Operations of BioMérieux Asia Pacific, Zheng Laifu, Senior Director of Corporate Business Development of BioMérieux Asia Pacific, Xiao Guohua, Co-Founder and Director of Acono Biotech, and Wu Kai, Director of Accunome Biotech. The strategic partnership will enable further collaboration and commercialization in the field of life and health.